Exploring Participant Preference for Screening Methods and Experience Into Colorectal Cancer Screening Programme (MS-Care)

September 29, 2025 updated by: ADVANCED MARKER DISCOVERY S.L.

The goal of this low-risk interventional study is to analyze participants' assessment of colorectal cancer screening program through screening method preference and experience after FOBT analysis in screaned participant population for colorectal cancer; could include any of the following: both sexes, age 50-69 years, asympthomatic volunteers. The main aims to answer are:

  • Values of experience of participants into screening programme.
  • Values of preferences of participants for screening methods.

Participants will answer two questionnaires and they'll be given their information and clinical data to investigator or health personnel.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Multicentre, international (Spain and Portugal), no-competitive, prospective, transversal and low-risk interventional study coming from average risk participants (50-69 years old) from the colorectal cancer screening programme who are eligible to undergo analysis for screening FOBT to analyze participants' assessment of colorectal cancer screening program through screening method preference and experience after FOBT analysis.

Study Type

Interventional

Enrollment (Estimated)

1000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Portugal
      • Lisbon, Portugal
        • Not yet recruiting
        • UCSP Sete Rios
        • Contact:
          • Ana Rita, MD
  • Spain
    • Madrid
      • Madrid, Madrid, Spain
        • Recruiting
        • CS Mar Báltico
        • Contact:
          • Maria A Perez, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Participants ages from 50 to 69 years (both included) at the time of informed consent signed.
  • Participants invited to participate in population-based screening programme who are eligible to undertake FOBT at the Primary Health Care Center.
  • Participants should sign an informed consent. They must understand the nature, significance, implications, and risks of the clinical study before signing the informed consent form.

Exclusion Criteria:

  • Participants who have not delivery a stool sample in the Primary Health Care Center before signing the informed consent form.
  • Participants with a previous colonoscopy in consequence of a FOBT positive result.
  • Participants who are in a dependent personal or non-medical relationship with the Sponsor or the Investigators.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: FIT/FOBT population
Average-risk population undergoing FIT/FOBT within the colorectal cancer screening programme.
Other: Survey using a questionnaire.
Preference questionnaire for colorectal cancer screening methods
Other: Survey using a questionnaire.
Experience questionnaire into colorectal cancer screening programme

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Value of questionnaires into screening programme
Time Frame: 12 months
The percentage of number of answers from each experience and preference questions
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

ADVANCED MARKER DISCOVERY S.L.

Collaborators

SERMAS
ULS de Santa Maria

Investigators

  • Principal Investigator: Maria A Perez, MD, Primary Health Care Centre Mar Báltico
  • Principal Investigator: Ana Rita, MD, Unidade Local de Saúde de Santa Maria

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 19, 2025

Primary Completion (Estimated)

November 1, 2025

Study Completion (Estimated)

December 1, 2025

Study Registration Dates

First Submitted

November 12, 2024

First Submitted That Met QC Criteria

November 16, 2024

First Posted (Actual)

November 20, 2024

Study Record Updates

Last Update Posted (Estimated)

October 2, 2025

Last Update Submitted That Met QC Criteria

September 29, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AMD-CCR-2024-01
  • 2024-NDMH-5101_240046 (Other Grant/Funding Number: EIT-Health)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Survey and Questionnaire

Clinical Trials on Survey using a questionnaire.

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe